Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo

Circulation

Volumn 97, Issue 15, 1998, Pages 1481-1487

  Gries, André ^a   Bode, Christoph ^b   Peter, Karlheinz ^b   Herr, Axel ^b   Böhrer, Hubert ^b   Motsch, Johann ^b   Martin, Eike ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Fibrinogen; Nitric oxide; P selectin; Platelets; Respiration

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRINOGEN; NITRIC OXIDE; PADGEM PROTEIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; BLOOD OXYGENATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0032554683     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.15.1481     Document Type: Article

References (48)

1. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987; 305:1057-1058.
2. 2+ and on aggregation of human platelets. Eur J Pharmacol. 1993;244:37-47.
3. Loscalzo J. Antiplatelet and anithrombotic effects of organic nitrates. Am J Cardiol. 1992;70:18B-22B.
4. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340: 818-819.
5. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide in adult respiratory distress syndrome. N Engl J Med. 1993; 328:399-405.
6. Sellden H, Winberg P, Gustaffson LE, Lundell B, Böök K, Frostell CG. Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2 kg infant. Anesthesiology. 1993;78:577-580.
7. Pearl RG. Inhaled nitric oxide: the past, the present, and the future. Anesthesiology. 1993;78:413-416.
8. Högman M, Frostell C, Arnberg H, Sandhagen B, Hedenstiema G. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand. 1994;151:125-129.
9. Högman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet. 1993;341:1664-1665. Letter.
10. Samama CM, Diaby M, Fellahi JL, Mdhafar A, Eyraud D, Arock M, Guillosson JJ, Coriat P, Rouby JJ. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology. 1995;83:56-65.
11. Gries A, Böttiger BW, Dörsam J, Bauer H, Weimann J, Bode C, Martin E, Motsch J. Inhaled nitric oxide inhibits platelet aggregation following pulmonary embolism in pigs. Anesthesiology. 1997;86:387-393.
12. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987;92:181-187.
13. Amano M, Takahashi M, Kosaka T, Kinoshita M. Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide. J Cardiovasc Pharmacol. 1994;24:860-866.
14. Chirkov YY, Naujalis JI, Barber S, Sage RE, Gove DW, Brealey JK, Horowitz JD. Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects. Am J Cardiol. 1992;70:802-806.
15. Karlberg KE, Torfgard K, Ahlner J, Sylvén C. Dose-dependent effect of intravenous nitroglycerin on platelet aggregation, and correlation with plasma glyceryl dinitrate concentration in healthy men. Am J Cardiol. 1992;69:802-805.
16. Harris SN, Rinder CS, Rinder HM, Tracey JB, Smith BR, Hines R. Nitroprusside inhibition of platelet function is transient and reversible by catecholamine priming. Anesthesiology. 1995;83:1145-1152.
17. Bassenge E. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors. Eur Heart J. 1991;12(suppl E):12-15.
18. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927-929.
19. Gawaz MP, Dobos G, Späth M, Schollmeyer P, Gurland HJ, Mujais SK. Impaired function of platelet membrane glycoprotein IIb-IIIa in end stage renal disease. J Am Soc Nephrol. 1994;5:36-46.
20. Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation. 1993;88:1502-1511.
21. Langford EJ, Wainwright RJ, Martin JF. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol. 1996;16:51-55.
22. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, and the Consensus Committee. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
23. Kratzer MAA, Born GVR. Simulation of primary hemostasis in vitro. Hemostasis. 1985;15:357-362.
24. Moncada S, Palmer MJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:108-142.
25. Werns SW, Rote WE, Davis JH, Guevara T, Lucchesi BR. Nitroglycerin inhibits experimental thrombosis and reocclusion after thrombolysis. Am Heart J. 1994;127:727-737.
26. Michelson AD, Benoit SE, Furman MI, Breckwoldt WL, Rohrer MJ, Barnard MR, Loscalzo J. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol. 1996;270:H1640-H1648.
27. Rovira I, Chen TY, Winkler M, Kawai N, Bloch KD, Zapol WM. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol. 1994;76:345-355.
28. Albert J, Wallen NH, Broijersen A, Frostell C, Hjemdahl P. Effects of inhaled nitric oxide compared with aspirin on platelet function in vivo in healthy subjects. Clin Sci (Colch). 1996;91:225-231.
29. Roberts JD Jr, Chen TY, Kawai N, Wain J, Dupuy P, Shimouchi A, Bloch K, Polaner D, Zapol WM. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res. 1993; 72:246-254.
30. Hébert D, Xiang JX, Lam JYT. Persistent inhibition of platelets during continuous nitroglycerin therapy despite hemodynamic tolerance. Circulation. 1997;95:1308-1313.
31. Simon DI, Stamler JS, Loh E, Loscalzo J, Francis SA, Creager MA. Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovasc Pharmacol. 1995;26:339-342.
32. Adrie C, Bloch KD, Moreno PR, Hurford WE, Guerrero JL, Holt R, Zapol WM, Gold HK, Semigran MJ. Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation. 1996;94: 1919-1926.
33. Vallance P, Benjamin N, Collier J. The effect of endothelium-derived nitric oxide on ex vivo whole blood aggregation in man. Eur J Clin Pharmacol. 1992;42:37-41.
34. Shernan S, Fox J, Body S, Morse D, Magnami B. Inhaled nitric oxide does not inhibit platelets in healthy human volunteers. Anesthesiology. 1996;85:A139. Abstract.
35. Lee JS, Adrie C, Jacob HJ, Roberts JD Jr, Zapol WM, Bloch KD. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res. 1996;78:337-342.
36. Krejcy K, Schmetterer L, Kastner J, Nieszpaur-Los M, Monitzer B, Schutz W, Eichler HG, Kyrle PA. Role of nitric oxide in hemostatic system activation in vivo in humans. Arterioscler Thromb Vasc Biol. 1995;15:2063-2067.
37. Murohara T, Parkinson SJ, Waldmann SA, Lefer AM. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets: role of protein kinase C. Arterioscler Thromb Vasc Biol. 1995;15:2068-2075.
38. Langford EJ, Brown AS, Wainwright RJ, de Belder AJ, Thomas MR, Smith REA, Martin JF, Moncada S. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet. 1994;344: 1458-1460.
39. Lees C, Langford E, Brown AS, de Belder A, Pickles A, Martin JF, Campbell G. The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia. Obstet Gynecol. 1996;88:14-19.
40. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology. 1994;107:1050-1058.
41. Malmros C, Blomquist S, Dahm P, Martensson L, Thörne J. Nitric oxide inhalation decreases pulmonary platelet and neutrophil sequestration during extracorporeal circulation in the pig. Crit Care Med. 1996;24: 845-849.
42. Bacha EA, Herve P, Murakami S, Chapelier A, Mazmanian GM, de Montpreville V, Detruit H, Libert JM, Dartevelle P. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. J Thorac Cardiavasc Surg. 1996;112:590-598.
43. Salas E, Moro MA, Askew S, Hodson HF, Butler AR, Radomski MW, Moncada S. Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br J Pharmacol. 1994;112:1071-1076.
44. Simon DI, Stamler JS, Jaraki O, Keaney JF, Osborne JA, Francis SA, Singel DJ, Loscalzo J. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb. 1993;13:791-799.
45. Wagne. CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood. 1996;88:907-914.
46. Lechi C, Andrioli G, Gaino S, Tommasoli R, Zuliani V, Ortolani R, Degan M, Benoni G, Bellavite P, Lechi A, Minuz P. The antiplatelet effect of a new nitroderivate of acetylic acid: an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production. Thromb Haemost. 1996;76:791-798.
47. Keh D, Gerlach M, Kurer I, Seiler S, Kerner T, Falke KJ, Gerlach H. The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human alpha-thrombin. Blood Coagul Flbrinolysis. 1996;7:615-624.
48. Pickles DM, Ogston D, MacDonald AG. Effects of gas bubbling and other forms of convection on platelets in vitro. J Appl Physiol. 1989;67: 1250-1255.